Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Saft

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
The Lancet. Neurology|December 3, 2014
What is the course of Huntington's disease?Carsten Saft
The Lancet. Neurology|June 18, 2022
Huntington's disease: disappointments and new beginningsCarsten Saft
The Lancet. Neurology|June 24, 2017
Identifying modifiers of Huntington's disease progressionCarsten Saft
Brain Structure & Function|October 19, 2013
Action selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary choreaChristian Beste, Carsten Saft
Parkinsonism & Related Disorders|May 28, 2021
Data from ENROLL-HD: Is the prevalence of juvenile and pediatric Huntington's disease overestimated?Jannis Achenbach, Carsten Saft
Brain Sciences|December 24, 2021
Another Perspective on Huntington's Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HDJannis Achenbach, Carsten Saft
Neuropsychologia|May 20, 2014
Benign hereditary chorea as an experimental model to investigate the role of medium spiny neurons for response adaptationChristian Beste, Carsten Saft
Brain Research|February 1, 2020
Antiepileptic effects of cobalt, manganese and magnesium on bicuculline-induced epileptiform activity in hippocampal neuronsCarsten Saft, Erwin-Josef Speckmann
Journal of Neurology|May 28, 2022
Resurrection of sildenafil: potential for Huntington's Disease, too?Jannis Achenbach, Simon Faissner, Carsten Saft
Brain Sciences|April 3, 2021
Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington's Disease-Data from a Real World CohortJannis Achenbach, Carsten Saft, Simon Faissner
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
The Lancet. Neurology|December 3, 2014
What is the course of Huntington's disease?Carsten Saft
The Lancet. Neurology|June 18, 2022
Huntington's disease: disappointments and new beginningsCarsten Saft
The Lancet. Neurology|June 24, 2017
Identifying modifiers of Huntington's disease progressionCarsten Saft
Brain Structure & Function|October 19, 2013
Action selection in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary choreaChristian Beste, Carsten Saft
Parkinsonism & Related Disorders|May 28, 2021
Data from ENROLL-HD: Is the prevalence of juvenile and pediatric Huntington's disease overestimated?Jannis Achenbach, Carsten Saft
Brain Sciences|December 24, 2021
Another Perspective on Huntington's Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HDJannis Achenbach, Carsten Saft
Neuropsychologia|May 20, 2014
Benign hereditary chorea as an experimental model to investigate the role of medium spiny neurons for response adaptationChristian Beste, Carsten Saft
Brain Research|February 1, 2020
Antiepileptic effects of cobalt, manganese and magnesium on bicuculline-induced epileptiform activity in hippocampal neuronsCarsten Saft, Erwin-Josef Speckmann
Journal of Neurology|May 28, 2022
Resurrection of sildenafil: potential for Huntington's Disease, too?Jannis Achenbach, Simon Faissner, Carsten Saft
Brain Sciences|April 3, 2021
Longitudinal Evaluation of the Effect of Tricyclic Antidepressants and Neuroleptics on the Course of Huntington's Disease-Data from a Real World CohortJannis Achenbach, Carsten Saft, Simon Faissner
Pageof 15